Stock Forecast
As of Sat Feb 20 2021 00:00:02 GMT+0000 (Coordinated Universal Time) shares of APRE Aprea Therapeutics 3.32 percentage change in price since the previous day's close. Around 863729 of 21187000 changed hand on the market. The Stock opened at 6.57 with high and low of 6.56 and 6.99 respectively. The price/earnings ratio is: - and earning per share is -2.3. The stock quoted a 52 week high and low of 4.66 and 41.12 respectively.
BOSTON (AI Forecast Terminal) Mon, Feb 22, '21 AI Forecast today took the forecast actions: In the context of stock price realization of APRE Aprea Therapeutics is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+7) for APRE Aprea Therapeutics as below:
APRE Aprea Therapeutics Credit Rating Overview
We rerate APRE Aprea Therapeutics because of add or deduct cumulative effect of credit-spread-related revaluation of liabilities. We use econometric methods for period (n+7) simulate with Royer Oscillators ANOVA. Reference code is: 1614. Beta DRL value REG 39 Rational Demand Factor LD 6177.3516. Shared facilities with captive finance entities. When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for APRE Aprea Therapeutics as below:
Frequently Asked Questions
Q: What is APRE Aprea Therapeutics stock symbol?A: APRE Aprea Therapeutics stock referred as NASDAQ:APRE
Q: What is APRE Aprea Therapeutics stock price?
A: On share of APRE Aprea Therapeutics stock can currently be purchased for approximately 6.85
Q: Do analysts recommend investors buy shares of APRE Aprea Therapeutics ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for APRE Aprea Therapeutics at daily forecast section
Q: What is the earning per share of APRE Aprea Therapeutics ?
A: The earning per share of APRE Aprea Therapeutics is -2.3
Q: What is the market capitalization of APRE Aprea Therapeutics ?
A: The market capitalization of APRE Aprea Therapeutics is 145130947
